Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
#507 Are all Metastatic Grade 3 WHO 2010 Neuroendocrine Carcinoma Poorly Differentiated?
Introduction: The WHO classification 2010 for neuroendocrine tumors (NET) defines poorly differentiated neuroendocrine carcinomas (NEC) as grade 3 (G3) according to mitoses> 20/10 HPF and/or Ki-67>20%.
Conference: 9th Annual ENETSConcerence (2012)
Presenting Author:
Authors: Vélayoudom-Céphise F, Duvillard P, Malka D, Leboulleux S, Guigay J,
Keywords: proliferation index, neuroendocrine tumors,
Introduction: Everolimus (E) is an mTOR inhibitor with promising antitumor activity in patients with NETs. Predictor factors of response could improve the clinical use of this compound.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: De Martino M, Ducreux M, Dromain C, Duvillard P, Guigay J, Leboulleux S,
Keywords: everolimus, mTOR, RECIST, pancreas, neuroendocrine, tumor, proliferative index, predictor,
#282 Characteristics of Patients with Well-differentiated Metastatic Lung Neuroendocrine Tumors
Introduction: Characteristics of well-differentiated lung neuroendocrine tumors (WDLNET) are poorly characterized at the metastatic stage.
Conference: 8th Annual ENETSConcerence (2011)
Presenting Author:
Authors: Chougnet C, Guigay J, Borget I, Leboulleux S, Duvillard P,
Keywords: lung NET, metastases, somatostatin analog, somatostatin recpetor scintigraphy ,